Intellia Therapeutics Head office building

Investors
& Media

Banner Menu

Press Releases

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More

Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million

Read More

Upcoming
Events

More events are coming soon.

Stock Information

Minimum 15 minutes delayed. Source: LSEG